Taro Pharmaceutical Industries Ltd. (TARO) Social Stream
TARO PHARMACEUTICAL INDUSTRIES LTD (TARO) Price Targets From Analysts
Use the tables below to see what analysts covering TARO PHARMACEUTICAL INDUSTRIES LTD think about its future price and what recommendations they have for investors and traders.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
Price Target Last Issued August 15, 2022
The Trend in the Analyst Price Target
Over the past 13 months, TARO's average price target has gone down $28.
Over the past 30 weeks, TARO's average upside potential has been 65.83%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
TARO Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 153 days, TARO's average broker recommendation rating improved by 0.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- TARO PHARMACEUTICAL INDUSTRIES LTD's number of analysts covering the stock is higher than nearly none of all US stocks.
- To contextualize these metrics, consider that out of all US stocks, TARO PHARMACEUTICAL INDUSTRIES LTD's variance in analysts' estimates is lower than nearly 100% of them.
- TARO has a higher average analyst price target than 318.98% of Pharmaceutical Products stocks.
- TARO has a higher upside potential (average analyst target price relative to current price) than 289.56% of stocks in the mid market cap category.
Make investment decisions regarding TARO using the data that counts. Try POWR Ratings for free.